PPARA and pulmonary arterial hypertension: Peroxisome proliferator-activated receptor-Υ (PPAR-Υ) expression has been observed to be reduced in patients with severe PAH while normal levels seen in patients with otherwise normal lungs but also in those with chronic obstructive pulmonary disease (COPD).